Loading...

VOR VOR BIOPHARMA INC Investor Conferences 8-K Filing

VR B

VR

VOR BIOPHARMA INC

(VOR)

2025 8-K

Summary

Summary

Stock Split Update

Corporate Presentation Update

Management Changes

Stockholder Approval

Licensing Agreement

Equity Offerings

Workforce Reduction

Noncompliance with Listing ...

Management Change

Stock Option Repricing

Board Appointment

Private Placement

Clinical Data Update

CFO Appointment

Resignation and Appointment

Equity Incentive Plan Amend...

Appointment of Director

Clinical Update

Annual Meeting of Stockholders

Resignation of Director

Clinical Update

External Links:

Vor Biopharma Inc. filed an 8-K report on September 2, 2025, to share a recent corporate presentation available on their website, which outlines the company's business activities.

AI Assistant

VOR BIOPHARMA INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.